Balasubramaniam Annamalai
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complement Inactivating Agents | 3 | 2021 | 56 | 2.130 |
Why?
|
| Retinal Pigment Epithelium | 7 | 2022 | 145 | 2.070 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 5 | 2020 | 51 | 1.400 |
Why?
|
| Choroidal Neovascularization | 4 | 2022 | 35 | 1.260 |
Why?
|
| Macular Degeneration | 3 | 2022 | 75 | 1.110 |
Why?
|
| Disease Models, Animal | 12 | 2022 | 2550 | 0.930 |
Why?
|
| Biological Transport | 3 | 2020 | 210 | 0.900 |
Why?
|
| Complement Pathway, Alternative | 2 | 2021 | 69 | 0.900 |
Why?
|
| Complement Activation | 3 | 2021 | 145 | 0.780 |
Why?
|
| Capsules | 2 | 2020 | 18 | 0.780 |
Why?
|
| Immunoglobulin M | 2 | 2021 | 172 | 0.770 |
Why?
|
| Serotonin | 3 | 2020 | 144 | 0.750 |
Why?
|
| Synaptosomes | 2 | 2020 | 57 | 0.740 |
Why?
|
| Complement Factor H | 1 | 2020 | 21 | 0.720 |
Why?
|
| Laminin | 1 | 2020 | 62 | 0.720 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 75 | 0.710 |
Why?
|
| Proteoglycans | 1 | 2020 | 103 | 0.700 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 511 | 0.630 |
Why?
|
| Collagen | 1 | 2020 | 636 | 0.570 |
Why?
|
| Tomography, Optical Coherence | 3 | 2021 | 88 | 0.550 |
Why?
|
| Cell Line | 8 | 2021 | 1752 | 0.520 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 3 | 2014 | 21 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 2791 | 0.460 |
Why?
|
| S-Nitrosoglutathione | 4 | 2015 | 87 | 0.460 |
Why?
|
| Threonine | 2 | 2010 | 47 | 0.440 |
Why?
|
| Endocytosis | 3 | 2019 | 113 | 0.430 |
Why?
|
| Serine | 2 | 2010 | 99 | 0.430 |
Why?
|
| Tyrosine | 2 | 2015 | 196 | 0.410 |
Why?
|
| Animals | 18 | 2022 | 20880 | 0.400 |
Why?
|
| Mice | 11 | 2022 | 8474 | 0.390 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2021 | 35 | 0.370 |
Why?
|
| Extracellular Vesicles | 2 | 2020 | 21 | 0.360 |
Why?
|
| Amphetamine | 1 | 2010 | 77 | 0.360 |
Why?
|
| Elastin | 2 | 2021 | 116 | 0.350 |
Why?
|
| Receptor, EphA2 | 1 | 2009 | 3 | 0.350 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2009 | 46 | 0.330 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 236 | 0.320 |
Why?
|
| Central Nervous System Stimulants | 1 | 2010 | 221 | 0.310 |
Why?
|
| Neuroprotective Agents | 3 | 2015 | 317 | 0.300 |
Why?
|
| Retinal Pigments | 3 | 2022 | 61 | 0.280 |
Why?
|
| Cell Movement | 1 | 2009 | 630 | 0.280 |
Why?
|
| Phosphorylation | 7 | 2015 | 1200 | 0.270 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2016 | 37 | 0.260 |
Why?
|
| tau Proteins | 2 | 2015 | 61 | 0.250 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 261 | 0.250 |
Why?
|
| Epithelial Cells | 3 | 2022 | 431 | 0.230 |
Why?
|
| Wet Macular Degeneration | 1 | 2022 | 2 | 0.210 |
Why?
|
| Blotting, Western | 2 | 2021 | 954 | 0.200 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 16 | 0.190 |
Why?
|
| Choroid | 1 | 2021 | 22 | 0.190 |
Why?
|
| Smoke | 1 | 2021 | 46 | 0.190 |
Why?
|
| Complement System Proteins | 2 | 2020 | 135 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 2083 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2018 | 35 | 0.190 |
Why?
|
| Complement C3 | 1 | 2021 | 101 | 0.190 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 236 | 0.190 |
Why?
|
| Receptors, IgG | 1 | 2021 | 94 | 0.180 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 742 | 0.180 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 84 | 0.180 |
Why?
|
| Bruch Membrane | 1 | 2020 | 6 | 0.180 |
Why?
|
| Protein Stability | 2 | 2011 | 89 | 0.180 |
Why?
|
| Biological Availability | 1 | 2020 | 79 | 0.180 |
Why?
|
| Corpus Striatum | 2 | 2020 | 278 | 0.180 |
Why?
|
| Geographic Atrophy | 1 | 2020 | 5 | 0.180 |
Why?
|
| Receptors, Histamine | 1 | 2020 | 3 | 0.180 |
Why?
|
| Protein Domains | 1 | 2020 | 74 | 0.180 |
Why?
|
| Receptors, Complement 3d | 1 | 2020 | 45 | 0.180 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 104 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 376 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2021 | 215 | 0.170 |
Why?
|
| Eye | 1 | 2020 | 89 | 0.170 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.170 |
Why?
|
| Transfection | 1 | 2021 | 782 | 0.170 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2019 | 20 | 0.170 |
Why?
|
| Retina | 1 | 2021 | 252 | 0.170 |
Why?
|
| Biological Products | 1 | 2020 | 78 | 0.160 |
Why?
|
| Receptors, Complement | 1 | 2019 | 58 | 0.160 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.160 |
Why?
|
| GABAergic Neurons | 1 | 2018 | 17 | 0.160 |
Why?
|
| Regeneration | 1 | 2019 | 105 | 0.150 |
Why?
|
| Neoplasms | 1 | 2009 | 1664 | 0.150 |
Why?
|
| Gene Expression | 1 | 2020 | 770 | 0.150 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1174 | 0.150 |
Why?
|
| Rats | 6 | 2022 | 5300 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2020 | 434 | 0.150 |
Why?
|
| Protein Kinase C | 2 | 2010 | 270 | 0.150 |
Why?
|
| Cell Membrane | 3 | 2015 | 524 | 0.140 |
Why?
|
| Neurons | 3 | 2019 | 881 | 0.130 |
Why?
|
| Mitochondria | 1 | 2020 | 643 | 0.130 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 565 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 184 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2015 | 447 | 0.120 |
Why?
|
| Diterpenes, Clerodane | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hippocampus | 1 | 2018 | 471 | 0.120 |
Why?
|
| Dopamine Agents | 1 | 2014 | 56 | 0.120 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 82 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 247 | 0.110 |
Why?
|
| Humans | 11 | 2022 | 68549 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 331 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2015 | 2689 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 268 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2015 | 506 | 0.100 |
Why?
|
| Smoking | 1 | 2020 | 1449 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 498 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2015 | 64 | 0.100 |
Why?
|
| Male | 4 | 2021 | 37283 | 0.090 |
Why?
|
| Biotinylation | 1 | 2010 | 27 | 0.090 |
Why?
|
| Trophoblasts | 1 | 2010 | 29 | 0.090 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2010 | 20 | 0.090 |
Why?
|
| Desipramine | 1 | 2010 | 47 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 26 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2011 | 284 | 0.090 |
Why?
|
| Brain | 3 | 2015 | 2176 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2016 | 326 | 0.090 |
Why?
|
| Calpain | 3 | 2015 | 205 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2022 | 2673 | 0.090 |
Why?
|
| Placenta | 1 | 2010 | 101 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 342 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2015 | 665 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2009 | 85 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2009 | 71 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 322 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 306 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 331 | 0.080 |
Why?
|
| Ligands | 2 | 2019 | 317 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 929 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1213 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1851 | 0.060 |
Why?
|
| Maze Learning | 2 | 2015 | 138 | 0.060 |
Why?
|
| Random Allocation | 2 | 2015 | 442 | 0.050 |
Why?
|
| Dabigatran | 1 | 2022 | 35 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 94 | 0.050 |
Why?
|
| Thrombin | 1 | 2022 | 117 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 351 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 219 | 0.050 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2020 | 5 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2020 | 28 | 0.040 |
Why?
|
| Clathrin | 1 | 2019 | 17 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 316 | 0.040 |
Why?
|
| Immunization | 1 | 2020 | 86 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 1329 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 1082 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 168 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2020 | 222 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2020 | 236 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1446 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 507 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 567 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2022 | 753 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2018 | 115 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 481 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2020 | 234 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 1030 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Peroxynitrous Acid | 1 | 2015 | 55 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 57 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Lysosomes | 1 | 2015 | 136 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 134 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 216 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 191 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 434 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 290 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 1040 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 483 | 0.030 |
Why?
|
| Female | 2 | 2015 | 38021 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 621 | 0.030 |
Why?
|
| Dopamine | 1 | 2014 | 474 | 0.030 |
Why?
|
| United States | 1 | 2022 | 7338 | 0.020 |
Why?
|
| Alanine | 1 | 2006 | 38 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 77 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 137 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 204 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 791 | 0.020 |
Why?
|